CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 101 enrolled
Drug / intervention
ropivacaine +4 moredrug
Likely dose
ropivacaine 300mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00901628
NCT00901628Phase 4Completed

Efficacy and Safety of Periarticular Multimodal Drug Injections in Total Knee Arthroplasty

Seoul National University Hospital·interventional·Posted May 14, 2009·Updated Jan 25, 2013

In Brief

A Phase 4 clinical trial evaluating ropivacaine, morphine sulfate, and 3 other interventions for Osteoarthritis, Knee. Completed, enrolled 101 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether periarticular multimodal drug injection (PMDI) would provide additional benefits in patients after total knee arthroplasty (TKA) for whom contemporary pain control protocols using the continuous femoral nerve block, intra-venous patient controlled analgesia (IV-PCA)and preemptive oral medications. We hypothesized that PMDI would reduce pain level and consumption of PCA and acute pain rescuer and would provide better functional recovery and patient satisfaction. We also hypothesized that the incidence of side effects and complications of the PMDI would be similar to the No-PMDI.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSouth Korea
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 14, 2009
Enrollment StartApr 1, 2008
Primary CompletionMar 1, 2009
Study CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 17.1 years ago

Interventions

ropivacainedrug

300mg (0.75%, 40cc) intraoperative periarticular injection

morphine sulfatedrug

10mg intraoperative periarticular injection

ketorolacdrug

30 mg intraoperative periarticular injection

epinephrinedrug

300 microgram (1:1000) intraoperative periarticular injection

cefuroximedrug

750mg intraoperative periarticular injection